Lipocine
LPCN
LPCN
25 hedge funds and large institutions have $2.73M invested in Lipocine in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 8 closing their positions.
Holders
25
Holders Change
-5
Holders Change %
-16.67%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
9
Closed
8
Calls
$28K
Puts
–
Net Calls
+$28K
Net Calls Change
-$61K
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
JPMorgan Chase & Co
New York
| – | – | -5,613 | Closed |
|
27
Jacobs Levy Equity Management
Florham Park,
New Jersey
| – | – | -3,532 | Closed |
|
28
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | – | -3,152 | Closed |
|
|
VF
29
Virtu Financial
New York
| – | – | -1,211 | Closed |
|
|
ARTA
30
A.R.T. Advisors
New York
| – | – | -699 | Closed |
|
31
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | – | -465 | Closed |
|
32
UBS Group
Zurich,
Switzerland
| – | – | -403 | Closed |
|
33
Simplex Trading
Chicago,
Illinois
| – | – | -86 | Closed |
|
|
CFGS
34
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|